BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 5913817)

  • 1. [CPIB: a hypolipidemic agent. Study of 20 patients].
    Verdy M
    Union Med Can; 1966 Sep; 95(9):1049-52. PubMed ID: 5913817
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical experimentation with CPIB (with or without androsterone) in the treatment of hyperlipemia. Apropos of 35 cases].
    Warembourg H; Jaillard J
    Lille Med; 1965 Apr; 10(4):431-6. PubMed ID: 5318637
    [No Abstract]   [Full Text] [Related]  

  • 3. [Action of a 2.2 percent solution of androsterone, in chlorphenisate, on the serum lipoproteins of low density (LDL) in patients resistant to diet therapy].
    Bertolami V; Schneiderman B; Finatti AA; Netto RF
    Arq Bras Cardiol; 1966 Apr; 19(2):111-26. PubMed ID: 5943772
    [No Abstract]   [Full Text] [Related]  

  • 4. [The effect of ethyl-chlorophenoxyisobutyrate on the serum lipids in coronary sclerosis].
    Keller L; Rétsági G; Sebestyén M; Diczendy S; Erdélyi G
    Z Gesamte Inn Med; 1966 Mar; 21(6):169-72. PubMed ID: 5988081
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment of hyperlipidemia with the ethyl-ester of chlorophenoxyisobutyrate and androsterone.
    Schatz IJ
    Henry Ford Hosp Med J; 1965 Dec; 13(4):447-56. PubMed ID: 5325188
    [No Abstract]   [Full Text] [Related]  

  • 6. Hypolipidemic agents--newly approved.
    Duncan GG
    Pa Med; 1967 Aug; 70(8):75-6. PubMed ID: 6073724
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effect of Atromid on blood lipids in patients with hyperlipemia].
    Baranova LV
    Ter Arkh; 1968 Mar; 40(3):15-20. PubMed ID: 4875984
    [No Abstract]   [Full Text] [Related]  

  • 8. [Experience with 110 medium-length therapeutic trials of ethyl chlorophenoxyisobutyrate with or without androsterone in various types of idiopathic hyperlipidemia].
    De Gennes JL; Maunand B; Salmon D; Laudat P; Truffert J
    Rev Atheroscler (Paris); 1966; 8(1):27-52. PubMed ID: 5961027
    [No Abstract]   [Full Text] [Related]  

  • 9. [The therapeutic use of CPIB in pathological increase of the lipid constituents of the blood].
    Cloarec M; Cottet J; Etienne J; Loeper J
    Sem Ther; 1965 Nov; 41(9):499-500. PubMed ID: 5877602
    [No Abstract]   [Full Text] [Related]  

  • 10. Observations on the effect of ethyl a-p chlorophenoxyisobutyrate (CPIB) therapy on serum lipid levels and on diabetic and some other retinopathies.
    Vannas S; Esilä R; Tuovinen E
    Acta Ophthalmol (Copenh); 1968; 46(2):162-70. PubMed ID: 5755673
    [No Abstract]   [Full Text] [Related]  

  • 11. [Studies on lipemia in elderly persons and the lipid lowering effect of a clofibrate derivate in 2 groups of test persons].
    Rilliet B; Monnier J
    Praxis; 1969 Jun; 58(25):815-20. PubMed ID: 5819485
    [No Abstract]   [Full Text] [Related]  

  • 12. A controlled trial of Atromid therapy in exudative diabetic retinopathy.
    Cullen JF; Ireland JT; Oliver MF
    Trans Ophthalmol Soc U K (1962); 1964; 84():281-95. PubMed ID: 5227423
    [No Abstract]   [Full Text] [Related]  

  • 13. Ethyl chlorophenoxyisobutyrate (CPIB) effects in juvenile-onset diabetes mellitus.
    Danowski TS; Cohn RE; Limaye NR; Novak JF; Saul R; Sunder JH; Moses C
    Clin Pharmacol Ther; 1965; 6(6):716-30. PubMed ID: 5321221
    [No Abstract]   [Full Text] [Related]  

  • 14. Foam cells in the renal glomerulus.
    McKenzie IF; Kincaid-Smith P
    J Pathol; 1969 Jan; 97(1):151-4. PubMed ID: 5783631
    [No Abstract]   [Full Text] [Related]  

  • 15. Divergent effects in the treatment of hyperlipemia.
    Slowe IA; Carter AC; Feldman EB
    Arch Intern Med; 1965 Oct; 116(4):523-30. PubMed ID: 5835355
    [No Abstract]   [Full Text] [Related]  

  • 16. [Action of ethyl chlorophenoxyisobutyrate (CPIB) on blood lipids].
    Giannini SD; da Silva WN; Luthold WW; Coelho LT; Bitelli T
    Rev Bras Med; 1965 Nov; 22(11):702-7. PubMed ID: 5892979
    [No Abstract]   [Full Text] [Related]  

  • 17. Atromid-S for the reduction of plasma lipids.
    Med Lett Drugs Ther; 1967 Jun; 9(12):45-7. PubMed ID: 6037633
    [No Abstract]   [Full Text] [Related]  

  • 18. Hypolipidemic effect of chlorophenoxyisobutyrate in adult-onset diabetes mellitus.
    Danowski TS; Novak JF; Saul RW; Vester JW; Moses C
    Clin Pharmacol Ther; 1966; 7(5):631-8. PubMed ID: 5957168
    [No Abstract]   [Full Text] [Related]  

  • 19. [Atromid].
    Borchgrevink CF
    Tidsskr Nor Laegeforen; 1967 Mar; 87(5):334. PubMed ID: 6039533
    [No Abstract]   [Full Text] [Related]  

  • 20. [Effect of atromide on some indices of the lipid metabolism in hypercholesterinemic patients].
    Baranova LV
    Kardiologiia; 1965; 5(4):65-6. PubMed ID: 5880736
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.